Lucid Diagnostics Net Profit Margin 2021-2024 | LUCD
Lucid Diagnostics Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2024-12-31 | $0.00B | $-0.05B | -1325.00% |
2024-09-30 | $0.00B | $-0.05B | -1300.00% |
2024-06-30 | $0.00B | $-0.05B | -1350.00% |
2024-03-31 | $0.00B | $-0.05B | -1800.00% |
2023-12-31 | $0.00B | $-0.05B | -2600.00% |
2023-09-30 | $0.00B | $-0.06B | -5600.00% |
2023-06-30 | $0.00B | $-0.06B | 0.00% |
2022-12-31 | $0.00B | $-0.06B | 0.00% |
2022-09-30 | $0.00B | $-0.05B | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $0.136B | $0.004B |
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK. |